Formula and production method of saxagliptin metformin sustained release tablet

The revised saxagliptin metformin sustained-release tablet formulation and production method address solubility issues by optimizing raw material ratios and water addition, resulting in enhanced dissolution performance and quality.

CN119055606APending Publication Date: 2024-12-03SHANGHAI PUKANG PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411122049.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing saxagliptin metformin sustained-release tablets exhibit poor solubility due to suboptimal preparation processes, leading to inefficiencies in dissolution rate and efficiency.

Method used

A revised formulation and production method involving specific ratios of metformin hydrochloride, sodium carboxymethylcellulose, hypromellose, microcrystalline cellulose, silicon dioxide, magnesium stearate, and saxagliptin, along with controlled water addition during granulation, ensures uniform particle size and appropriate hardness, enhancing dissolution properties.

Benefits of technology

The revised tablets demonstrate improved dissolution rate and efficiency, with controlled hardness and friability within optimal ranges, meeting pharmaceutical standards and exceeding the performance of prior art tablets.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119055606A_ABST
    Figure CN119055606A_ABST
Patent Text Reader

Abstract

The invention discloses a saxagliptin and metformin sustained release tablet formula, and relates to the technical field of pharmaceutical preparations. Each ten thousand of tablets are prepared from the following raw materials by mass: 4.96 kg to 5.04 kg of metformin hydrochloride, 0.48 kg to 0.52 kg of sodium carboxymethyl cellulose, 83.28 kg to 3.32 kg of hydroxypropyl methylcellulose 220, 0.66 kg to 0.74 kg of microcrystalline cellulose, 0.08 kg to 0.12 kg of hydroxypropyl methylcellulose 2910, 0.18 kg to 0.22 kg of silicon dioxide, 0.19 kg to 0.21 kg of magnesium stearate, 2.58 kg to 2.62 kg of purified water and 0.048 kg to 0.052 kg of saxagliptin. In the granulating process, the raw materials are supplemented with appropriate water in each stage, the hardness of the tablets prepared by spraying too much water becomes soft, and the hardness of the tablets prepared by spraying too little water becomes hard, so that the prepared tablets are moderate in hardness, the dissolution of the tablets can be accelerated, and the dissolution rate and the dissolution efficiency of the tablets are remarkably improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of pharmaceutical preparations, and in particular to a formula of a saxagliptin metformin sustained-release tablet and a production method thereof. Background Art

[0002] Diabetes is a common chronic comprehensive disease. Diabetes is a common and frequently occurring disease characterized by high blood sugar. There are two types of diabetes: insulin-dependent and non-insulin-dependent. Currently, the main drug for the treatment of diabetes is saxagliptin metformin sustained-release tablets.

[0003] After searching, the Chinese patent publication number is CN112494485B, which discloses a saxagliptin and metformin hydrochloride sustained-release tablet and its preparation process. The sustained-release tablet is composed of a metformin hydrochloride sustained-release tablet core, a sealing layer, a saxagliptin upper drug layer, and a colored layer from the inside to the outside; wherein the metformin hydrochloride sustained-release tablet core includes metformin hydrochloride, cellulose acetate, a dissolving skeleton material, and an adhesive; and the saxagliptin upper drug layer includes saxagliptin, adipic acid, and Opadry II coating materials.

[0004] The prior art is similar to the above-mentioned saxagliptin metformin sustained-release tablets, which use metformin hydrochloride, cellulose acetate, soluble skeleton material, adhesive, saxagliptin and adipic acid as main raw materials, wet granulation, drying, and granulation to obtain drug particles, and the drug particles are mixed with micro-powder silica gel, and tableted to obtain metformin hydrochloride sustained-release tablet cores. The preparation process is relatively simple, resulting in poor solubility of the produced saxagliptin metformin sustained-release tablets, so there is room for improvement. Summary of the invention

[0005] The purpose of the present invention is to solve the shortcomings of the prior art and propose a formula of saxagliptin metformin sustained-release tablets and a production method thereof. The advantages are that in the process of granulation, the raw materials are supplemented with appropriate water at each stage, and the hardness of the prepared tablets will become soft if too much water is sprayed, and the hardness of the tablets will be harder if too little water is sprayed, so that the prepared tablets are moderately soft and hard, and the dissolution of the tablets can be accelerated, and the dissolution rate and dissolution efficiency of the tablets are significantly improved.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] A formula for saxagliptin metformin sustained-release tablets, wherein each 10,000 tablets are composed of the following raw materials by mass: 4.96kg-5.04kg of metformin hydrochloride, 0.48kg-0.52kg of sodium carboxymethylcellulose, 3.28kg-3.32kg of hypromellose 2208, 0.66kg-0.74kg of microcrystalline cellulose, 0.08kg-0.12kg of hypromellose 2910, 0.18kg-0.22kg of silicon dioxide, 0.19kg-0.21kg of magnesium stearate, 2.58kg-2.62kg of purified water and 0.048kg-0.052kg of saxagliptin.

[0008] Preferably, each 10,000 tablets are composed of the following raw materials by mass: 4.96 kg of metformin hydrochloride, 0.52 kg of sodium carboxymethylcellulose, 3.28 kg of hypromellose 2208, 0.74 kg of microcrystalline cellulose, 0.08 kg of hypromellose 2910, 0.22 kg of silicon dioxide, 0.21 kg of magnesium stearate, 2.58 kg of purified water and 0.052 kg of saxagliptin.

[0009] Preferably, each 10,000 tablets are composed of the following raw materials by mass: 5.00 kg of metformin hydrochloride, 0.50 kg of sodium carboxymethylcellulose, 3.30 kg of hypromellose 2208, 0.70 kg of microcrystalline cellulose, 0.10 kg of hypromellose 2910, 0.20 kg of silicon dioxide, 0.20 kg of magnesium stearate, 2.60 kg of purified water and 0.05 kg of saxagliptin.

[0010] Preferably, each 10,000 tablets are composed of the following raw materials in weight: 5.04 kg of metformin hydrochloride, 0.48 kg of sodium carboxymethylcellulose, 3.32 kg of hypromellose 2208, 0.66 kg of microcrystalline cellulose, 0.12 kg of hypromellose 2910, 0.18 kg of silicon dioxide, 0.19 kg of magnesium stearate, 2.62 kg of purified water and 0.048 kg of saxagliptin.

[0011] Preferably, the 10,000-grain tablet further comprises coating materials, which consist of film coating premix, hydrochloric acid, sodium hydroxide and purified water.

[0012] A method for producing saxagliptin metformin sustained-release tablets comprises the following steps:

[0013] Step 1: Weigh the prescribed amount of metformin hydrochloride, sodium carboxymethyl cellulose, hypromellose 2208, silicon dioxide, microcrystalline cellulose, hypromellose 2208, hypromellose 2910 and magnesium stearate for later use;

[0014] Step 2: Add metformin hydrochloride and sodium carboxymethylcellulose into a fluidized bed drying granulator, set the fan frequency to 35 Hz, turn off the heating, and mix for 10 minutes;

[0015] Step 3: Set the air inlet opening to 90°, the fan frequency to 35Hz, the air inlet temperature to 80.0℃, the atomization pressure to 0.25MPa-0.35MPa for the inner layer and 0.20MPa-0.30MPa for the outer layer, weigh 39kg of purified water, set the liquid supply speed to 300r / min, and start water spraying and granulation when the material temperature reaches 45℃. When the material temperature reaches 45℃, turn off the heating; pump 1 / 3 of the prescribed amount of Hydroxypropyl Methylcellulose 2208 into the boiling drying granulator and boil for 5-10min; during production, take samples at the sampling port after boiling for 5min and 10min respectively to detect moisture, collect moisture values, and the internal control standard of 10min granule moisture is 2-5%;

[0016] Step 4: Add the prescribed amount of silicon dioxide into the material cabin and use the lifting and turning granulator for granulation. Install a 1.5mm screen on the granulator. Push the silo of the boiling dryer under the dry granulator. Tighten the 6 connecting screws of the barrel cover and seal it. Operate the lifting machine to turn the barrel 180° and raise it to an appropriate height. Push the 1000L mixing tank so that the discharge port of the mixing tank is aligned with the feed port of the dry granulator. The discharge port of the dry granulator is aligned with the mixing tank port and fixed with a hose. Start the granulator, set the granulation speed to 10Hz, open the discharge knob of the barrel cover, and granulate.

[0017] Step 5: Add the granulated particles into the mixing barrel, and then add the remaining amount of HPMC 2208, microcrystalline cellulose and HPMC 2910, and mix for 25 minutes; then add magnesium stearate, and mix for 5 minutes; after mixing, place the prepared receiving barrel to the discharge port, open the discharge butterfly valve, and slowly put the material into a clean container lined with a plastic bag;

[0018] Step 6: Use a fully automatic high-speed handwheel-free tablet press to press the tablets. During the production process, the tablets fall into the tablet sifter for sifting, and the sifted tablets are placed in a clean container lined with a plastic bag;

[0019] Step 7: After tableting, the tablets are coated with an isolation layer, a drug layer and a protective layer respectively, and then the inner and outer packages are respectively carried out after coating, thereby completing the production of saxagliptin metformin sustained-release tablets.

[0020] The present invention is further configured that, before tabletting, tableting shall be tested, and the operating personnel shall check the appearance, average tablet weight, and tablet weight difference of the test tableting products. Only when all the requirements are met can production be carried out; when changing batches, the test tableting shall be checked for the appearance, average tablet weight, tablet weight difference, hardness and friability of the test tableting products. Only when all the requirements are met can the operator carry out normal production.

[0021] The present invention is further configured that, during the tablet pressing process, the operator should take 10 tablets at the tablet press outlet and weigh them once every 15 minutes, calculate the average tablet weight, and mark it in the trend chart on the attached page of the tablet pressing record, and draw a tablet weight trend chart in time. If the measurement result during the inspection is within the limit, if there is a trend of exceeding the limit, the operator should make appropriate adjustments to the equipment, and after the adjustment, take another sample for inspection.

[0022] The present invention is further configured as follows: the metformin hydrochloride is pulverized by a pulverizer and passed through an 80-mesh screen, and the sodium carboxymethylcellulose is pulverized by a pulverizer and passed through an 80-mesh screen; and the hypromellose 2208, microcrystalline cellulose, and hypromellose 2910 are pulverized by a pulverizer and passed through a 60-mesh screen.

[0023] The present invention is further configured that after the water spraying granulation, the liquid supply speed is increased by 25r / min every 5 minutes; when the liquid supply frequency reaches 450r / min, the liquid supply speed is maintained until the water spraying is completed.

[0024] The beneficial effects of the present invention are:

[0025] The invention discloses a saxagliptin metformin sustained-release tablet. A reasonable raw material ratio is adopted for production. After tableting, the tablet weight difference, hardness and friability of the tablet are all within a preferred numerical range, and the yield rate is very high. At the same time, a specific preparation method is adopted for the raw materials: after the raw materials are screened, the size of the raw materials will be relatively uniform, and during the granulation process, the adhesion between the raw material molecules will be relatively large and not easy to loosen. After the water spraying mode is changed, during the granulation process, appropriate water will be added to the raw materials at each stage. If too much water is sprayed, the hardness of the prepared tablet will become soft, and if too little water is sprayed, the hardness of the tablet will be relatively hard, so that the prepared tablet has moderate hardness and softness, can accelerate the dissolution of the tablet, and significantly improve the dissolution rate and dissolution efficiency of the tablet. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 A schematic diagram of the raw material composition structure of a saxagliptin metformin sustained-release tablet proposed in the present invention;

[0027] Figure 2 The present invention provides a schematic diagram of the preparation process of the saxagliptin metformin sustained-release tablets. DETAILED DESCRIPTION

[0028] The technical solution of this patent is further described in detail below in conjunction with specific implementation methods.

[0029] The embodiments of the present invention are described in detail below, and examples of the embodiments are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.

[0030] Example 1

[0031] Reference Figure 1 , a formula for saxagliptin metformin sustained-release tablets, each 10,000 tablets is composed of the following raw materials in mass:

[0032] Element Dosage per 10,000 tablets (kg) Metformin Hydrochloride 4.96 Sodium carboxymethylcellulose 0.52 Hydroxypropyl methylcellulose 2208 3.28 Microcrystalline Cellulose 0.74 Hydroxypropyl methylcellulose 2910 0.08 Silicon dioxide 0.22 Magnesium Stearate 0.21 Purified water 2.58 Saxagliptin 0.052

[0033] Example 2

[0034] Reference Figure 1 , a formula for saxagliptin metformin sustained-release tablets, each 10,000 tablets is composed of the following raw materials in mass:

[0035] Element Dosage per 10,000 tablets (kg) Metformin Hydrochloride 5.00 Sodium carboxymethylcellulose 0.50 Hydroxypropyl methylcellulose 2208 3.30 Microcrystalline Cellulose 0.70 Hydroxypropyl methylcellulose 2910 0.10 Silicon dioxide 0.20 Magnesium Stearate 0.20 Purified water 2.60 Saxagliptin 0.05

[0036] Example 3

[0037] Reference Figure 1 , a formula for saxagliptin metformin sustained-release tablets, each 10,000 tablets is composed of the following raw materials in mass:

[0038]

[0039]

[0040] In the above embodiment, the 10,000-grain tablets further include coating materials, which consist of film coating premix, hydrochloric acid, sodium hydroxide and purified water.

[0041] Reference Figure 2 The method for producing the saxagliptin metformin sustained-release tablets disclosed in the above-mentioned embodiments 1-3 comprises the following steps:

[0042] Step 1: Weigh the prescribed amount of metformin hydrochloride, sodium carboxymethyl cellulose, hypromellose 2208, silicon dioxide, microcrystalline cellulose, hypromellose 2208, hypromellose 2910 and magnesium stearate for later use;

[0043] Step 2: Add metformin hydrochloride and sodium carboxymethylcellulose into a fluidized bed drying granulator, set the fan frequency to 35 Hz, turn off the heating, and mix for 10 minutes;

[0044] Step 3: Set the air inlet opening to 90°, the fan frequency to 35Hz, the air inlet temperature to 80.0℃, the atomization pressure to 0.25MPa-0.35MPa for the inner layer and 0.20MPa-0.30MPa for the outer layer, weigh 39kg of purified water, set the liquid supply speed to 300r / min, and start water spraying and granulation when the material temperature reaches 45℃. When the material temperature reaches 45℃, turn off the heating; pump 1 / 3 of the prescribed amount of Hydroxypropyl Methylcellulose 2208 into the boiling drying granulator and boil for 5-10min; during production, take samples at the sampling port after boiling for 5min and 10min respectively to detect moisture, collect moisture values, and the internal control standard of 10min granule moisture is 2-5%;

[0045] Step 4: Add the prescribed amount of silicon dioxide into the material cabin and use the lifting and turning granulator for granulation. Install a 1.5mm screen on the granulator. Push the silo of the boiling dryer under the dry granulator. Tighten the 6 connecting screws of the barrel cover and seal it. Operate the lifting machine to turn the barrel 180° and raise it to an appropriate height. Push the 1000L mixing tank so that the discharge port of the mixing tank is aligned with the feed port of the dry granulator. The discharge port of the dry granulator is aligned with the mixing tank port and fixed with a hose. Start the granulator, set the granulation speed to 10Hz, open the discharge knob of the barrel cover, and granulate.

[0046] Step 5: Add the granulated particles into the mixing barrel, and then add the remaining amount of HPMC 2208, microcrystalline cellulose and HPMC 2910, and mix for 25 minutes; then add magnesium stearate, and mix for 5 minutes; after mixing, place the prepared receiving barrel to the discharge port, open the discharge butterfly valve, and slowly put the material into a clean container lined with a plastic bag;

[0047] Step 6: Use a fully automatic high-speed handwheel-free tablet press to press the tablets. During the production process, the tablets fall into the tablet sifter for sifting, and the sifted tablets are placed in a clean container lined with a plastic bag;

[0048] Step 7: After tableting, the tablets are coated with an isolation layer, a drug layer and a protective layer respectively, and then the inner and outer packages are respectively carried out after coating, thereby completing the production of saxagliptin metformin sustained-release tablets.

[0049] Before tableting, a test tablet should be made, and the operator shall check the appearance, average tablet weight and tablet weight difference of the test tablet products. Production can only be carried out after they meet the requirements. When changing batches, the appearance, average tablet weight, tablet weight difference, hardness and friability of the test tablets shall be checked. After they meet the requirements, the operator can carry out normal production.

[0050] In order to compare the quality of tablets produced by the formula and method disclosed in the above embodiment with the quality of tablets produced by the formula and method of the prior art, four groups of comparative experiments were conducted to record the difference in tablet weight, hardness and friability after tableting. The statistical results are shown in the following table:

[0051] project Tablet weight difference (%) Hardness(N) Friability (%) Example 1 2.5 223 0.21 Example 2 1.8 190 0.12 Example 3 2.6 180 0.19 Prior art 3.2 176 0.25

[0052] It can be seen from the above table that according to the existing pharmaceutical production standards, in the tablet production process, the weight difference is controlled within 5%, the hardness is between 150N-250N and the friability is 0.6%. For the weight difference and friability, the smaller the value, the higher the tablet quality, and the closer the hardness is to the middle value, the more suitable the hardness is. According to the above analysis standards, Examples 1-3 and the prior art all meet the production standards. However, the quality of the tablets produced by Examples 1-3 is significantly better than that of the prior art, especially the tablets produced by the formula disclosed in Example 2 have the best quality.

[0053] During the tablet pressing process, the operator should take 10 tablets at the tablet press outlet and weigh them every 15 minutes, calculate the average tablet weight, and mark it in the trend chart on the attached page of the tablet pressing record. Draw the tablet weight trend chart in time. If the measurement results during the inspection are within the limit, if there is a trend of exceeding the limit, the operator should make appropriate adjustments to the equipment and take another sample for inspection after the adjustment.

[0054] Example 4

[0055] Reference Figure 2 , a method for producing a saxagliptin metformin sustained-release tablet formulation, this embodiment improves the production method based on the formulation disclosed in Example 2, comprising the following steps:

[0056] Step 1: Weigh the prescribed amount of metformin hydrochloride, sodium carboxymethyl cellulose, hypromellose 2208, silicon dioxide, microcrystalline cellulose, hypromellose 2208, hypromellose 2910 and magnesium stearate for use; use a grinder to grind metformin hydrochloride through an 80-mesh screen, and use a grinder to grind sodium carboxymethyl cellulose through an 80-mesh screen; use a grinder to grind hypromellose 2208, microcrystalline cellulose and hypromellose 2910 through a 60-mesh screen;

[0057] Step 2: Add metformin hydrochloride and sodium carboxymethylcellulose into a fluidized bed drying granulator, set the fan frequency to 35 Hz, turn off the heating, and mix for 10 minutes;

[0058] Step 3: Set the air inlet opening to 90°, the fan frequency to 35Hz, the air inlet temperature to 80.0℃, the atomization pressure to 0.25MPa-0.35MPa for the inner layer and 0.20MPa-0.30MPa for the outer layer, weigh 39kg of purified water, set the liquid supply speed to 300r / min, and start water spraying and granulation when the material temperature reaches 45℃, and increase it by 25r / min every 5 minutes; when the liquid supply frequency reaches 450r / min, maintain the liquid supply speed until the water spraying ends and the material temperature reaches 45℃, and turn off the heating; draw 1 / 3 of the prescribed amount of hydroxypropyl methylcellulose 2208 into the boiling drying granulator and boil for 5-10min; during production, take samples at the sampling port after boiling for 5min and 10min respectively to detect the moisture content, collect the moisture value, and the internal control standard of the 10min granule moisture content is 2-5%;

[0059] Step 4: Add the prescribed amount of silicon dioxide into the material cabin and use the lifting and turning granulator for granulation. Install a 1.5mm screen on the granulator. Push the silo of the boiling dryer under the dry granulator. Tighten the 6 connecting screws of the barrel cover and seal it. Operate the lifting machine to turn the barrel 180° and raise it to an appropriate height. Push the 1000L mixing tank so that the discharge port of the mixing tank is aligned with the feed port of the dry granulator. The discharge port of the dry granulator is aligned with the mixing tank port and fixed with a hose. Start the granulator, set the granulation speed to 10Hz, open the discharge knob of the barrel cover, and granulate.

[0060] Step 5: Add the granulated particles into the mixing barrel, and then add the remaining amount of HPMC 2208, microcrystalline cellulose and HPMC 2910, and mix for 25 minutes; then add magnesium stearate, and mix for 5 minutes; after mixing, place the prepared receiving barrel to the discharge port, open the discharge butterfly valve, and slowly put the material into a clean container lined with a plastic bag;

[0061] Step 6: Use a fully automatic high-speed handwheel-free tablet press to press the tablets. During the production process, the tablets fall into the tablet sifter for sifting, and the sifted tablets are placed in a clean container lined with a plastic bag;

[0062] Step 7: After tableting, the tablets are coated with an isolation layer, a drug layer and a protective layer respectively, and then the inner and outer packages are respectively carried out after coating, thereby completing the production of saxagliptin metformin sustained-release tablets.

[0063] In order to verify the effect of the above-mentioned method improvement on tablet quality, two groups of comparative experiments were conducted with Example 2, and the tablet weight difference, hardness and friability after tableting were recorded respectively. The statistical results are shown in the following table:

[0064] project Tablet weight difference (%) Hardness(N) Friability (%) Example 2 1.8 190 0.12 Example 4 1.2 200 0.08

[0065] From the comparison of the above tables, it can be seen that under the same raw material formula, Example 4 sieves the raw materials and changes the water spraying method on the basis of Example 2. Whether in terms of tablet weight difference, hardness and friability, it is better than Example 2. It can be seen that after the raw materials are sieved, the size of the raw materials will be more uniform. During the granulation process, the adhesion between the raw material molecules will be relatively large and not easy to loosen. After the water spraying method is changed, during the granulation process, the raw materials will be supplemented with appropriate water at each stage. If too much water is sprayed, the hardness of the prepared tablets will become soft, and if too little water is sprayed, the hardness of the tablets will be harder, so that the prepared tablets are moderately soft and hard, which can accelerate the dissolution of the tablets.

[0066] In order to verify the dissolution rate of the tablets prepared in Examples 1-4 and the prior art, five groups of comparative experiments were first conducted. The experimental method was as follows: pH 1.0 hydrochloric acid solution was used as the dissolution medium, the sustained-release tablets were put into the rotating basket and placed in a uniform position, the sampling time points were 1, 3, 6, 10, and 16 hours, and after sampling, the sustained-release tablet samples were placed directly below the cylindrical probe of the texture analyzer, and then the cylindrical probe was used to measure the sustained-release tablet samples, and the record table was as follows:

[0067]

[0068] It can be seen from the above table that the dissolution rates of Examples 1-4 and the prior art after 16 hours are all above 80%, which are in line with the quality standards of the drug. However, the dissolution rates of Examples 1-4 at any time point are significantly better than those of the prior art. The dissolution peak value and the dissolution rate in any time period of Example 4 are higher than those of the other four comparative examples. Therefore, the technical solution disclosed in the present invention can significantly improve the dissolution rate of saxagliptin metformin sustained-release tablets compared with the prior art.

[0069] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A formula of saxagliptin metformin sustained-release tablets, characterized in that: Each 10,000 tablets are composed of the following raw materials: 4.96kg-5.04kg of metformin hydrochloride, 0.48kg-0.52kg of sodium carboxymethylcellulose, 3.28kg-3.32kg of hypromellose 2208, 0.66kg-0.74kg of microcrystalline cellulose, 0.08kg-0.12kg of hypromellose 2910, 0.18kg-0.22kg of silicon dioxide, 0.19kg-0.21kg of magnesium stearate, 2.58kg-2.62kg of purified water and 0.048kg-0.052kg of saxagliptin.

2. A saxagliptin metformin sustained-release tablet formulation according to claim 1, characterized in that: Each 10,000 tablets are composed of the following raw materials: 4.96 kg of metformin hydrochloride, 0.52 kg of sodium carboxymethylcellulose, 3.28 kg of hypromellose 2208, 0.74 kg of microcrystalline cellulose, 0.08 kg of hypromellose 2910, 0.22 kg of silicon dioxide, 0.21 kg of magnesium stearate, 2.58 kg of purified water and 0.052 kg of saxagliptin.

3. A saxagliptin metformin sustained-release tablet formulation according to claim 1, characterized in that: Each 10,000 tablets are composed of the following raw materials: 5.00 kg of metformin hydrochloride, 0.50 kg of sodium carboxymethylcellulose, 3.30 kg of hypromellose 2208, 0.70 kg of microcrystalline cellulose, 0.10 kg of hypromellose 2910, 0.20 kg of silicon dioxide, 0.20 kg of magnesium stearate, 2.60 kg of purified water and 0.05 kg of saxagliptin.

4. A saxagliptin metformin sustained-release tablet formulation according to claim 1, characterized in that: Each 10,000 tablets are composed of the following raw materials: 5.04 kg of metformin hydrochloride, 0.48 kg of sodium carboxymethylcellulose, 3.32 kg of hypromellose 2208, 0.66 kg of microcrystalline cellulose, 0.12 kg of hypromellose 2910, 0.18 kg of silicon dioxide, 0.19 kg of magnesium stearate, 2.62 kg of purified water and 0.048 kg of saxagliptin.

5. A saxagliptin metformin sustained-release tablet formulation according to any one of claims 1 to 4, characterized in that: The 10,000-grain tablets also include coating materials, which consist of film coating premix, hydrochloric acid, sodium hydroxide and purified water.

6. A method for producing the saxagliptin metformin sustained-release tablets as claimed in claim 5, characterized in that: The following steps are involved: Step 1: Weigh the prescribed amount of metformin hydrochloride, sodium carboxymethyl cellulose, hypromellose 2208, silicon dioxide, microcrystalline cellulose, hypromellose 2208, hypromellose 2910 and magnesium stearate for later use; Step 2: Add metformin hydrochloride and sodium carboxymethylcellulose into a fluidized bed drying granulator, set the fan frequency to 35 Hz, turn off the heating, and mix for 10 minutes; Step 3: Set the air inlet opening to 90°, the fan frequency to 35Hz, the air inlet temperature to 80.0℃, the atomization pressure to 0.25MPa-0.35MPa for the inner layer and 0.20MPa-0.30MPa for the outer layer, weigh 39kg of purified water, set the liquid supply speed to 300r / min, and start water spraying and granulation when the material temperature reaches 45℃. When the material temperature reaches 45℃, turn off the heating; pump 1 / 3 of the prescribed amount of Hydroxypropyl Methylcellulose 2208 into the boiling drying granulator and boil for 5-10min; during production, take samples at the sampling port after boiling for 5min and 10min respectively to detect moisture, collect moisture values, and the internal control standard of 10min granule moisture is 2-5%; Step 4: Add the prescribed amount of silicon dioxide into the material cabin and use the lifting and turning granulator for granulation. Install a 1.5mm screen on the granulator. Push the silo of the boiling dryer under the dry granulator. Tighten the 6 connecting screws of the barrel cover and seal it. Operate the lifting machine to turn the barrel 180° and raise it to an appropriate height. Push the 1000L mixing tank so that the discharge port of the mixing tank is aligned with the feed port of the dry granulator. The discharge port of the dry granulator is aligned with the mixing tank port and fixed with a hose. Start the granulator, set the granulation speed to 10Hz, open the discharge knob of the barrel cover, and granulate. Step 5: Add the granulated particles into the mixing barrel, and then add the remaining amount of HPMC 2208, microcrystalline cellulose and HPMC 2910, and mix for 25 minutes; then add magnesium stearate, and mix for 5 minutes; after mixing, place the prepared receiving barrel to the discharge port, open the discharge butterfly valve, and slowly put the material into a clean container lined with a plastic bag; Step 6: Use a fully automatic high-speed handwheel-free tablet press to press the tablets. During the production process, the tablets fall into the tablet sifter for sifting, and the sifted tablets are placed in a clean container lined with a plastic bag; Step 7: After tableting, the tablets are coated with an isolation layer, a drug layer and a protective layer respectively, and then the inner and outer packages are respectively carried out after coating, thereby completing the production of saxagliptin metformin sustained-release tablets.

7. The method for producing a saxagliptin metformin sustained-release tablet formulation according to claim 6, characterized in that: Before tableting, a test tablet should be conducted, and the operator shall check the appearance, average tablet weight and tablet weight difference of the test tablet product. Production can only be carried out after they meet the requirements. When changing batches, the test tablet should be checked for appearance, average tablet weight, tablet weight difference, hardness and friability of the test tablet product. Only after they meet the requirements can the operator carry out normal production.

8. The method for producing a saxagliptin metformin sustained-release tablet formulation according to claim 7, characterized in that: During the tableting process, the operator should take 10 tablets at the tablet press outlet and weigh them every 15 minutes, calculate the average tablet weight, and mark it in the trend chart on the attached page of the tableting record, and draw a tablet weight trend chart in time. If the measurement results during the inspection are within the limit, if there is a trend of exceeding the limit, the operator should make appropriate adjustments to the equipment and take another sample for inspection after the adjustment.

9. The method for producing a saxagliptin metformin sustained-release tablet formulation according to claim 8, characterized in that: The metformin hydrochloride was pulverized by a pulverizer and passed through an 80-mesh screen, and sodium carboxymethylcellulose was pulverized by a pulverizer and passed through an 80-mesh screen; Hydroxypropyl methylcellulose 2208, microcrystalline cellulose, and Hydroxypropyl methylcellulose 2910 were pulverized by a pulverizer and passed through a 60-mesh screen.

10. The method for producing a saxagliptin metformin sustained-release tablet formulation according to claim 9, characterized in that: After the water spraying granulation, the speed is increased by 25 r / min every 5 minutes; when the liquid supply frequency reaches 450 r / min, the liquid supply speed is maintained until the water spraying is finished.